Literature DB >> 12429925

Phytochemicals as cell cycle modulators--a less toxic approach in halting human cancers.

Rana P Singh1, Sivanandhan Dhanalakshmi, Rajesh Agarwal.   

Abstract

The multistep nature of cancer development provides a rationale for cancer prevention. Activation of oncogenes, inactivation of tumor suppressor genes and modulation of mitogenic signal transduction pathways are critical in cancer progression and present attractive targets for cancer prevention/intervention. In this respect, cell cycle regulation and its modulation by various natural (plant-derived) and synthetic agents are gaining widespread attention in recent years. A number of phytochemicals inhibit cell cycle progression in cancer cells, yet their clinical applications are still in infancy. The present review is focused on the modulatory effects of phytochemicals on critical cell cycle molecules, and discusses how they inhibit proliferation and/or induce apoptotic death in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429925

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  38 in total

1.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

2.  EGCG improves recombinant protein productivity in Chinese hamster ovary cell cultures via cell proliferation control.

Authors:  Noriko Yamano; Takeshi Omasa
Journal:  Cytotechnology       Date:  2018-08-01       Impact factor: 2.058

3.  What is Xenohormesis?

Authors:  Joseph A Baur; David A Sinclair
Journal:  Am J Pharmacol Toxicol       Date:  2008-03-31

4.  Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway.

Authors:  Ran Wang; Wei-hong Cong; Gang Guo; Xiang-xin Li; Xue-liang Chen; Xiao-ning Yu; Hao Li
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

5.  Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells.

Authors:  Nupoor Prasad; Akash Sabarwal; Umesh C S Yadav; Rana P Singh
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

6.  p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Authors:  Srirupa Roy; Mallikarjuna Gu; Kumaraguruparan Ramasamy; Rana P Singh; Chapla Agarwal; Sunitha Siriwardana; Robert A Sclafani; Rajesh Agarwal
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

7.  Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.

Authors:  Rana P Singh; Komal Raina; Gagan Deep; Daniel Chan; Rajesh Agarwal
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators.

Authors:  Samiha Mateen; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2010-03       Impact factor: 4.784

9.  Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.

Authors:  Yan-Xia Guo; Zhao-Min Lin; Mei-Juan Wang; Yi-Wen Dong; Huan-Min Niu; Charles Yf Young; Hong-Xiang Lou; Hui-Qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

10.  1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane potentiates in vitro and in vivo antitumor effects of irinotecan on human colorectal cancer cells.

Authors:  Po-Sheng Yang; Jane-Jen Wang; Yea-Hwey Wang; Woan-Ching Jan; Shih-Ping Cheng; Yi-Chiung Hsu
Journal:  Oncol Lett       Date:  2016-04-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.